Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Ritu Randhawa Gill, M.D.

Co-Author

This page shows the publications co-authored by Ritu Gill and Paul Vanderlaan.
Connection Strength

0.243
  1. de Margerie-Mellon C, Gill RR, Salazar P, Oikonomou A, Nguyen ET, Heidinger BH, Medina MA, VanderLaan PA, Bankier AA. Assessing invasiveness of subsolid lung adenocarcinomas with combined attenuation and geometric feature models. Sci Rep. 2020 Sep 03; 10(1):14585.
    View in: PubMed
    Score: 0.062
  2. de Margerie-Mellon C, Ngo LH, Gill RR, Monteiro Filho AC, Heidinger BH, Onken A, Medina MA, VanderLaan PA, Bankier AA. The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT. Radiology. 2020 Oct; 297(1):189-198.
    View in: PubMed
    Score: 0.062
  3. Sehgal K, Bulumulle A, Brody H, Gill RR, Macherla S, Qilleri A, McDonald DC, Cherry CR, Shea M, Huberman MS, VanderLaan PA, Weiss GJ, Walker PR, Costa DB, Rangachari D. Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer. Clin Lung Cancer. 2020 Jun 05.
    View in: PubMed
    Score: 0.061
  4. de Margerie-Mellon C, Gill RR, Monteiro Filho AC, Heidinger BH, Onken A, VanderLaan PA, Bankier AA. Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume Measurements. Acad Radiol. 2020 Oct; 27(10):1385-1393.
    View in: PubMed
    Score: 0.059
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.